NFKB1 and cancer: Chronic inflammation, driven by persistent infections (e.g., H. pylori, HBV, and HCV), autoimmune disorders, or environmental insults (e.g., tobacco and obesity), which increase cancer risk [237, 278–280], is associated with sustained NF-κB activation in both immune and epithelial cells.